iRhythm Holdings, Inc. (IRTC) stock
Close on Nov 17, 2026Market cap $2.96BP/E –Yield –
iRhythm Holdings, Inc. grew revenue 25.6% to $825.34M over the twelve months to Jun 30, 2026. Free cash flow was $38.98M, up 39.8% from a year earlier. At the latest close the market valued the company at $2.96B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.96B
- P/E ratio
- –
- Price to sales
- 3.58
- Price to book
- 15.89
- Dividend yield
- –
- Free cash flow yield
- 1.32%
Fundamentals
- Revenue
- $825.34M
- Net income
- -$13.95M
- EPS, diluted
- -$0.43
- Free cash flow
- $38.98M
- Book value per share
- $5.65
- Diluted shares
- 33M
Trading
- Next earnings
- Feb 18, 2027 (estimated, after the close)
- Previous close
- $90.83
- Open
- $90.52
- Day's range
- $89.35 – $92.03
- Volume
- 590,216
- Average volume (20 days)
- 1,012,686
- Index membership
- Russell 2000, Russell 3000
- 52-week range
- $82.85 – $192.47
- RSI (14 days)
- 34.7
- Volatility (1 year)
- 53.9%
- Relative volume
- 1.08×
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2016, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.
| Period | IRTC | S&P 500 | Difference | IRTC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.5% | -4.0% | −13.4 pts | ||
| 3 months | -23.3% | -5.0% | −18.3 pts | ||
| Year to date | -49.5% | +8.2% | −57.7 pts | ||
| 1 year | -46.5% | +11.2% | −57.7 pts | ||
| 3 years | +10.1% | +68.5% | −58.4 pts | +3.3% | +19.0% |
| 5 years | -18.6% | +67.3% | −85.9 pts | -4.0% | +10.8% |
| 10 years | +226.6% | +291.6% | −65.0 pts | +12.6% | +14.6% |
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases iRhythm filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- Results
- Results
About iRhythm
Surgical & Medical Instruments & Apparatus
iRhythm is a digital healthcare company providing device-based technology for ambulatory cardiac monitoring. Its offerings combine wearable, patch-based biosensors with cloud-based data analytic software to monitor patients and assist in diagnosing arrhythmias, such as atrial fibrillation. Key systems include the Zio monitor, Zio XT, and Zio AT systems, which support long-term continuous monitoring and mobile cardiac telemetry services. Customers and users primarily comprise physicians, cardiology practices, electrophysiologists, primary care clinicians, integrated delivery networks, and value-based healthcare organizations.
Company profile, executives and historyiRhythm stock: common questions
What is iRhythm's stock price?
IRTC closed at $89.67 on Nov 17, 2026, down 1.28% on the day. Over the past 52 weeks it traded between $82.85 and $192.47.
What is iRhythm's market cap?
iRhythm was worth $2.96B at the close on Nov 17, 2026: the share price times the diluted shares outstanding.
What is IRTC's P/E ratio?
iRhythm lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.43), so it has no meaningful P/E ratio.
How much revenue does iRhythm make?
iRhythm reported revenue of $825.34M for the twelve months to Jun 30, 2026, up 25.6% from a year earlier.
Does iRhythm pay a dividend?
No. iRhythm has not paid a cash dividend over the last twelve months.
When does iRhythm report earnings next?
iRhythm is expected to report Q4 FY2026 results on Feb 18, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has IRTC stock performed over the past year?
Including dividends, IRTC returned -46.5% over the past year, against +11.2% for the S&P 500.
How many IRTC shares are sold short?
3M shares were sold short at the latest FINRA report, 10.12% of the float, or 6.7 days of average trading volume.
Who are iRhythm's competitors?
Companies most similar to iRhythm by business, industry and size include ATRC, INSP, TNDM, NVCR, HTFL.
See a number that looks wrong?